Key facts
- This page summarizes David Sholehvar's Form 4 filing for NEOGENOMICS INC (NEO).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 03 Aug 2022, 17:45.
David Sholehvar - 01 Aug 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)
- Reporting relationship
- President, Clinical Services
- Issuer ticker
- NEO
- Reported as of
- 01 Aug 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Aug 2022, 17:45:43 UTC
- Prior SEC filing
- 04 Apr 2022
- Next SEC filing
- 14 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ali Olivo, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David Sholehvar filed Form 4 for NEOGENOMICS INC (NEO) on 03 Aug 2022.
Change
- Previous filing in this sequence was filed on 04 Apr 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NEO
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +12,352
- Change %
- +40%
- Price
- $0.000000
- Shares after
- 43,216
- Date
- 01 Aug 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NEO
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +25,826
- Change %
- Price
- $0.000000
- Shares after
- 25,826
- Date
- 01 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,826
- Exercise price
- $10.12
- Footnotes
- F3
NEO
holding
Derivative
Stock Option (Right to Buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 66,372
- Date
- 01 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 66,372
- Exercise price
- $12.15
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
On August 1, 2022, Dr. Sholehvar was granted 12,352 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
Footnote F2
On April 1, 2022, Dr. Sholehvar was granted 66,372 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Footnote F3
On August 1, 2022, Dr. Sholehvar was granted 25,826 stock options. These options vest ratably over the first four anniversary dates of the grant date.